Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Study of Respiratory Syncytial Virus Monoclonal Antibody Therapy in High-risk Infants and Toddlers

NCT00420966 is registered in ClinicalTrials.gov with Sunnybrook Health Sciences Centre as lead sponsor.

NCT NCT00420966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00420966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Study of Respiratory Syncytial Virus Monoclonal Antibody Therapy in High-risk Infants and Toddlers
Lead sponsor
Sunnybrook Health Sciences Centre
Phase
Observational
Overall status
Completed
Start date
October 31, 2005
Completion date
June 26, 2017
Enrollment
25,003 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lower respiratory tract infection, respiratory syncytial virus infections